Photo: Todd Van Hoosear / Wikimedia Commons, CC BY-SA 2.0
CVS Health plans to divide its retail pharmacy chain from its insurance and pharmacy-benefit operations in early 2028, reversing a decade-long push to bring key parts of US healthcare under one corporate roof.
Two publicly traded companies
The planned separation will create two listed companies. One will contain CVS’s roughly 9,000 retail pharmacies, while the other will retain health insurer Aetna and pharmacy benefit manager CVS Caremark.
DGBN has also reported on Barry Callebaut Profit Outlook Misses Forecast as Cocoa Cost Risk Persists.
Chief executive David Joyner told the Wall Street Journal that CVS believed the businesses would be better served as separate companies. Reuters reported that one of the companies will keep the CVS Health name and that both businesses are expected to remain publicly traded.
Reports also indicate that the insurance-and-benefits company would retain CVS’s care-delivery assets, including Oak Street Health, Signify Health and its specialty pharmacy business. Existing shareholders are expected to hold shares in both new companies.
A reversal of the Aetna strategy
The split would unwind the structure created by CVS’s acquisition of Aetna in 2018, a transaction valued at about $78 billion. CVS had argued that combining a national pharmacy chain, an insurer and a major prescription-benefits manager could coordinate care and control costs.
Instead, the company is now moving away from a model that has increasingly drawn scrutiny from policymakers, regulators and consumer advocates. Pharmacy benefit managers, or PBMs, negotiate drug prices and administer prescription plans for insurers and employers, giving them substantial influence over where and how patients obtain medicines.
For more context, read DGBN’s coverage of APM Terminals calls for port upgrades to reduce Nigeria cargo delays.
The retail pharmacy business will be separated from Caremark, but Caremark and Aetna are set to remain together. That means the restructuring does not fully remove concerns surrounding common ownership of insurance and prescription-benefits operations.
Why it matters for Black communities
The change matters because CVS is a major point of access to prescriptions, vaccinations and everyday healthcare in many Black communities across the United States. Any restructuring that alters pharmacy networks, pricing arrangements, insurance coverage or service locations could have practical consequences for patients already facing unequal access to affordable care.
Black Americans experience persistent disparities in chronic illnesses including diabetes, hypertension and asthma, making reliable access to medicines and local pharmacists especially important. The planned separation does not itself change a patient’s insurance or prescription coverage, but the eventual structure and commercial agreements will need close scrutiny.
CVS has said the split should allow each business to focus more sharply on its own operations. However, analysts have warned that a spin-off can also reduce the cost savings created by shared services and introduce new corporate costs.
What happens next
The timetable points to the first half of 2028, leaving CVS more than a year to determine the legal, financial and operational details. The company’s plans arrive as PBMs face heightened political pressure over drug-pricing practices and their ownership links to insurers and pharmacies.
Related DGBN reporting includes World Bank urges Nigerian states to put people before road spending.
For customers and employees, the immediate message is continuity: the proposed transaction remains a future corporate restructuring, not an immediate change to pharmacies, Aetna plans or Caremark benefits. The key question will be whether the break-up improves accountability and affordability — or merely reshapes a healthcare system that many patients already find difficult to navigate.